Mediphase II LLC
Insider CIK 1572379 · TTPH 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 9,101,517 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 6,193,019 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 3,096,509 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,132,517 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 1,043,478 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 521,739 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 521,739 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,761,571 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 8,556,982 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 400,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 400,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 2,917,152 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion deriv | 2013-03-25 | 2013-03-27 | 800,000 | — | $0 | 0 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 121,428 | $7.00 | $850.0K | 540,592 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | P Buy | 2013-03-25 | 2013-03-27 | 164,285 | $7.00 | $1.15M | 765,208 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 100,591 | — | $0 | 100,591 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 295,068 | — | $0 | 600,923 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 95,226 | — | $0 | 248,153 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 313,845 | — | $0 | 419,164 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 213,552 | — | $0 | 305,855 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 106,776 | — | $0 | 152,927 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 73,535 | — | $0 | 105,319 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 35,982 | — | $0 | 92,303 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 17,991 | — | $0 | 46,151 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 17,991 | — | $0 | 31,784 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 27,586 | — | $0 | 56,321 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 13,793 | — | $0 | 28,160 | SEC↗ |
| TTPH TETRAPHASE PHARMACEUTICALS | C Conversion | 2013-03-25 | 2013-03-27 | 13,793 | — | $0 | 13,793 | SEC↗ |